SOLUTIONS

COVID-19 and Interstitial Lung Disease

COVID-19 and Interstitial Lung Disease

Interstitial lung diseases (ILDs), also known as diffuse parenchymal lung diseases, result from damage to the cells surrounding the alveoli (air sacs) leading to widespread inflammation and fibrotic scarring of the lungs
There are more than 300 different conditions that are classed as interstitial lung diseases.  Most are very rare; but the more common interstitial lung diseases include:

  1. Sarcoidosis
  2. Idiopathic pulmonary fibrosis (as is also the case in some COVID-19 patients)
  3. Extrinsic allergic alveolitis (also known as hypersensitivity pneumonitis)
  4. Interstitial lung disease associated with connective tissue disease
  5. Pneumoconiosis
  6. Interstitial lung disease caused by certain drugs used to treat other conditions

ILDs are an increasing burden on healthcare resources - better availability of specialised services is necessary in order to improve management of these conditions.